KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Cash & Equivalents (2016 - 2025)

Stereotaxis (STXS) has disclosed Cash & Equivalents for 16 consecutive years, with $13.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 9.86% to $13.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.4 million through Dec 2025, up 9.86% year-over-year, with the annual reading at $13.4 million for FY2025, 9.86% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $13.4 million at Stereotaxis, up from $10.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $43.9 million in Q1 2021, with the low at $5.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $22.4 million, with a median of $19.1 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents crashed 84.74% in 2023, then skyrocketed 213.59% in 2024.
  • Over 5 years, Cash & Equivalents stood at $40.1 million in 2021, then crashed by 78.61% to $8.6 million in 2022, then skyrocketed by 139.48% to $20.6 million in 2023, then crashed by 40.58% to $12.2 million in 2024, then rose by 9.86% to $13.4 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $13.4 million, $10.5 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.